- Home
- GNSS vs ADAG Comparison
GNSS vs ADAG Comparison
Compare GNSS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ADAG
- Stock Information
- Founded
- GNSS 1992
- ADAG 2011
- Country
- GNSS United States
- ADAG China
- Employees
- GNSS N/A
- ADAG N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- ADAG Health Care
- Exchange
- GNSS Nasdaq
- ADAG Nasdaq
- Market Cap
- GNSS 112.9M
- ADAG 110.8M
- IPO Year
- GNSS N/A
- ADAG 2021
- Fundamental
- Price
- GNSS $2.22
- ADAG $1.79
- Analyst Decision
- GNSS Strong Buy
- ADAG Strong Buy
- Analyst Count
- GNSS 1
- ADAG 3
- Target Price
- GNSS $5.75
- ADAG $7.67
- AVG Volume (30 Days)
- GNSS 286.6K
- ADAG 81.2K
- Earning Date
- GNSS 08-14-2025
- ADAG 08-12-2025
- Dividend Yield
- GNSS N/A
- ADAG N/A
- EPS Growth
- GNSS N/A
- ADAG N/A
- EPS
- GNSS N/A
- ADAG N/A
- Revenue
- GNSS $30,470,000.00
- ADAG $103,204.00
- Revenue This Year
- GNSS $90.97
- ADAG $7,411.34
- Revenue Next Year
- GNSS $75.75
- ADAG $28.29
- P/E Ratio
- GNSS N/A
- ADAG N/A
- Revenue Growth
- GNSS 8.95
- ADAG N/A
- 52 Week Low
- GNSS $1.46
- ADAG $1.33
- 52 Week High
- GNSS $4.04
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- GNSS 48.28
- ADAG 37.02
- Support Level
- GNSS $2.11
- ADAG $1.75
- Resistance Level
- GNSS $2.32
- ADAG $2.00
- Average True Range (ATR)
- GNSS 0.15
- ADAG 0.11
- MACD
- GNSS -0.04
- ADAG -0.02
- Stochastic Oscillator
- GNSS 22.92
- ADAG 12.13
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.